GlassScriptPhysician profile
Hui Gong
NPI 1316189426
$1,677.60
in general payments reported to CMS, 2019-2025
12 companies · $531 in 2025
The $531 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $60.80 · 2022: $90.03 · 2023: $461 · 2024: $391 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,384.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $687.49 | 2023-2025 | Xcopri |
| Livanova USA, INC. | $433.57 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $287.96 | 2022-2024 | Briviact, Fintepla |
| Sumitomo Pharma America, INC. | $123.85 | 2023 | Aptiom |
| Sunovion Pharmaceuticals INC. | $60.80 | 2020 | |
| Tg Therapeutics, INC. | $32.06 | 2025 | |
| Biogen, INC. | $27.96 | 2025 | Vumerity, Tysabri |
| Greenwich Biosciences, INC. | $23.91 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hui Gong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.